Drug intelligence / Profile preview

Osteobrix Plus

Development stage
Unknown
Lead developer
Stevia Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Osteobrix Plus is an approved combination nutritional supplement developed by Stevia Pharmaceuticals in India. It is formulated as a softgel capsule containing elemental calcium, calcitriol (the active hormonal form of Vitamin D3), methylcobalamin (Vitamin B12), folic acid (Vitamin B9), and pyridoxine (Vitamin B6). Calcitriol functions as a Vitamin D receptor (VDR) agonist, enhancing intestinal calcium absorption and promoting bone mineralization, while elemental calcium provides the structural component for bone tissue. The inclusion of B-vitamins addresses common nutritional deficiencies and supports neurological and metabolic health. It is primarily indicated for the management of bone health and nutritional deficiencies.

Brand names
Osteobrix Plus
Other names
Osteobrix Plus Capsules
02

Targets

MTR (Methionine synthase)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Osteobrix Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteobrix Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call